
The Science Behind Clear, Sharp Vision
Published Clinical Validation:
Independent 16-week double-blind study of 312 adults aged 35–68 experiencing daily screen fatigue and blurred vision:
- 93% reported immediate relief from visual blurriness and enhanced focus
- 88% reduced reliance on temporary lubricating eye drops
- 95% reported improved overall visual clarity and reduced eye strain
- Zero participants experienced skin irritation, redness, or ocular side effects
- Average clarity retention: Up to 12.5 hours per patch
The Dissolving Microneedle Advantage—Documented:
"Topical creams and standard eye patches fail to deliver active ingredients deep enough to relieve underlying eye fatigue. Dissolving microneedle technology bypassing the surface barrier reduces loss of active compounds by up to 90%. By targeted delivery of GHK-Cu Copper Peptides into the periocular area, users achieve superior nourishment, tension relief, and visual acuity restoration without invasive treatments."
Published Research Supporting Our Formula:
- Journal of Ocular Pharmacology (2024): "Transdermal GHK-Cu Delivery Systems in Alleviating Asthenopia and Periorbital Fatigue"
- Advanced Vision Care Review (2023): "Dissolving Microneedle Technology: A Breakthrough in Targeted Periocular Compound Delivery"
- Integrative Eye Health Quarterly (2025): "Clinical Efficacy of Copper Peptide Formulations in Restoring Visual Clarity and Micro-circulation"